+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Membrane Chromatography Market - Growth, Trends, and Forecasts (2020 - 2025)

  • PDF Icon


  • 112 Pages
  • June 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4896217
UP TO OFF until Jun 30th 2023
Membrane chromatography is a well-established technology in bioprocessing that is routinely used in the capture of large particles such as viruses and viral vectors, and also in polishing steps for the removal of DNA, host cell protein impurities (HCP) and virus. There is an increasing demand for biopharmaceuticals and increasing regulatory scrutiny on the cleaning validation of downstream purification processes are the major factors for the growth of this market.

However, the limited use of membrane chromatography in large-scale manufacturing is expected to restrain the growth of this market during the forecast period.

Key Market Trends

Ion Exchange Membrane Chromatography is Expected to Cover a Large Share of the Market

Ion-exchange chromatography (IC) is a chromatography process that separates ions and polar molecules based on their affinity to the ion exchanger. It works on almost any kind of charged molecule, including large proteins, small nucleotides, and amino acids.

There has been a growing interest in the application of IC in the analysis of pharmaceutical drugs. IC is used in different aspects of product development and quality control testing. In one scuh example, IC is used to improve stabilities and solubility properties of pharmaceutical active drugs molecules as well as used to detect systems that have higher tolerance for organic solvents.IC is also widely used for detection and quantification of excipients or inactive ingredients used in pharmaceutical formulations.

The large share of this segment has been attributed to its wide applications in antibody polishing and virus purification due to the advantages associated with ion exchange membrane chromatography, such as scalability, robustness, disposable nature, high throughput, rapid processing, reduced buffer consumption, and a validation-free environment.

North America is Expected to Dominate the Membrane Chromatography Market

North America includes the United States (US), Canada and Mexico. The US and Canada have well structured and development healthcare systems. These countries also promote pharmaceutical research and development and hence have very high expenditure on healthcare. As a result of these policies, many companies globally are encouraged to operate in this region.

Many of the global pharmaceutical players have their headquarters and research labs in the US. As pharmaceutical research requires membrane chromatography, the demand for these technologies and processes is high is North America.This large share can be attributed to the increasing demand for biopharmaceuticals and rising R&D expenditure by biopharmaceutical companies in North America.

Competitive Landscape

The majority of the membrane chromatography technique and processe instruments are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Biopharmaceuticals
4.2.2 Increasing Regulatory Scrutiny on the Cleaning Validation of Downstream Purification Processes
4.2.3 Increasing R&D Expenditure in the Biopharmaceutical Industry
4.3 Market Restraints
4.3.1 Limited Use of Membrane Chromatography Products in Large-Scale Manufacturing
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Capsules & Cartridges
5.1.2 Syringe Filters
5.1.3 Membrane Filters
5.1.4 Filter Plates
5.1.5 Spin Columns
5.1.6 Others Consumables and Accessories
5.2 By Technique
5.2.1 Ion Exchange Membrane Chromatography
5.2.2 Affinity Membrane Chromatography
5.2.3 Hydrophobic Interaction Membrane Chromatography (HIMC)
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 3M
6.1.2 Asahi Kasei
6.1.3 Cole-Parmer
6.1.4 Danaher Corporation
6.1.5 GE Healthcare
6.1.6 Membrane Solutions
6.1.7 Merck KGaA
6.1.8 Purilogics
6.1.9 Sartorius AG
6.1.10 Thermo Fisher Scientific

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3M
  • Asahi Kasei
  • Cole-Parmer
  • Danaher Corporation
  • GE Healthcare
  • Membrane Solutions
  • Merck KGaA
  • Purilogics
  • Sartorius AG
  • Thermo Fisher Scientific